PharmaNest Announces New Pre-Clinical and Clinical NASH Data to Be Presented at the AASLD – The Liver Meeting Digital Experience™ (TLMdX) 2021

NEXT STORY
Mustang Bio Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights
PREV STORY
Aileron Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Market for Infectious Diseases to Approach $100B by 2022

WELLESLEY, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Drivers of the infectious diseases market ...

author_avatar
NASDAQ Market News

Otonomy Initiates Patient Enrollment in Phase 2 Clinical Trial of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss

SAN DIEGO, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused ...

author_avatar
NASDAQ Market News

Athenex Announces Planned Retirement of Chief Financial Officer Nick Riehle

BUFFALO, N.Y., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical ...

author_avatar
NASDAQ Market News